Stable Isotope Labelled Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade

Reference: PX-TA1316-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Pinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade
SourceCAS 1313706-14-7
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000
ReferencePX-TA1316-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-CD22[Homo sapiens] (Pinatuzumab) Monoclonal Antibody

Pinatuzumab is investigated for the treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products